Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Openhousebiologics Discount Agreements 202610 Infliximab (dosage Form For Subcutaneous Injection) 2028-05-31
Germany Open House Originals Discount Agreements 2026-03 - Dolutegravir/rilpivirine (combination Of Active Ingredients) 2028-05-31
Germany Provision Of Verbandmittel. 2028-06-01
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2028-06-01
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2028-06-01
Germany Dydrogesterone/estradiol (atc: G03fa14; Except 2.5 Mg/0.5 Mg N1)_tk, Hek, Hkk 2028-06-01
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2028-06-01
Germany Finished Medicinal Product Name Smofkabiven (except Smofkabiven Ntense, Kpg) And Interchangeable Fam_tk, Hek, Hkk 2028-06-01
Germany Dydrogesterone (n2)_tk, Hek, Hkk 2028-06-01
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Companies For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2028-06-01
Whats app